Victory Capital Management Inc Cocrystal Pharma, Inc. Transaction History

Victory Capital Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$0.38 - $0.55 $32 - $47	-86 Reduced 0.68%	12,598 $5,000
Q1 2022 May 04, 2022	SELL	$0.48 - $0.71 $173 - $256	-361 Reduced 2.77%	12,684 $6,000
Q4 2021 Feb 07, 2022	SELL	$0.65 - $1.02 $263 - $414	-406 Reduced 3.02%	13,045 $8,000
Q3 2021 Nov 02, 2021	SELL	$1.01 - $1.25 $685 - $848	-679 Reduced 4.81%	13,451 $14,000
Q2 2021 Aug 03, 2021	BUY	$1.08 - $2.14 $15,260 - $30,238	14,130 New	14,130 $18,000
Q2 2020 Aug 07, 2020	SELL	$0.7 - $1.58 $4,045 - $9,130	-5,779 Closed	0 $0
Q1 2020 May 04, 2020	BUY	$0.48 - $2.19 $1,339 - $6,110	2,790 Added 93.34%	5,779 $4,000
Q4 2019 Feb 04, 2020	BUY	$0.39 - $2.05 $249 - $1,312	640 Added 27.25%	2,989 $2,000
Q3 2019 Nov 12, 2019	BUY	$1.69 - $2.88 $3,969 - $6,765	2,349 New	2,349 $5,000

Ticker COCP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,122,420
Market Cap $17.5M
Description
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company ...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.